XBI icon

SPDR S&P Biotech ETF

274 hedge funds and large institutions have $2.17B invested in SPDR S&P Biotech ETF in 2016 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 28 closing their positions.

Holders
274
Holders Change
+47
Holders Change %
+20.7%
% of All Funds
6.86%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
83
Increased
75
Reduced
72
Closed
28
Calls
$793M
Puts
$1.1B
Net Calls
-$307M
Net Calls Change
+$11.3M
Name Market Value Shares Shares
Change
Shares
Change %
CAPTRUST Financial Advisors
301
CAPTRUST Financial Advisors
North Carolina
-240 Closed
Mariner
302
Mariner
Kansas
-93 Closed
MWP
303
MYCIO Wealth Partners
Pennsylvania
-85 Closed
ACM
304
Argentus Capital Management
Texas
-41 Closed
Walleye Trading
305
Walleye Trading
New York
KPF
306
K2 Principal Fund
Ontario, Canada
HCM
307
Highbridge Capital Management
New York
BC
308
Broadfin Capital
New York
Nomura Holdings
309
Nomura Holdings
Japan
DA
310
DSC Advisors
Illinois
HCMT
311
Highland Capital Management (Texas)
Texas
EAM
312
EverPoint Asset Management
Connecticut
HT
313
HAP Trading
New York
AWM
314
Avior Wealth Management
Nebraska
ACM
315
Atika Capital Management
New York
Millennium Management
316
Millennium Management
New York
SGH
317
Sivik Global Healthcare
Connecticut
QF
318
QVT Financial
New York
ACP
319
Acuta Capital Partners
California
GTC
320
Ghost Tree Capital
New York
FO
321
FT Options
Illinois
JGC
322
J. Goldman & Co
New York
TI
323
Telemetry Investments
New York
ACPU
324
Arrowgrass Capital Partners (US)
Delaware
NM
325
Nokota Management
New York